GENE ONLINE|News &
Opinion
Blog

2022-04-12| In-Depth

Compensating for OxyContin: The Harm from Pharma

by Eduardo Longoria
Share To
ASGCT 2025 showcases MeiraGTx’s ALS and pediatric obesity therapies and Rgenta’s RSwitch technology for Friedreich’s ataxia.
The United States has seen 500,000 deaths from opioid overdoses in the two decades from 1999 to 2019 according to the U.S. Centers for Disease Control and Prevention. Of these deaths a larger percentage have come from commonly prescribed opioids than heroin until the year 2018. 

GO Prime with only $1.49 now

LATEST
Neurodegenerative and Metabolic Disease Challenges and Solutions at ASGCT 2025
2025-05-15
Boehringer Ingelheim and Tempus AI Partner in Multi-Year Collaboration to Enhance Oncology Drug Development
2025-05-15
Study: Aligning U.S. Drug Prices with Europe Could Reduce American Life Expectancy by Six Months
2025-05-15
Tribal Leaders Warn Senators: Federal Health Funding Cuts Threaten Native American Health.
2025-05-14
Health Secretary Kennedy Retracts Parts of Agency Reorganization Plan During Combative Congressional Hearing
2025-05-14
SURMOUNT-5 Trial: Zepbound Shows Greater Weight Loss Than Wegovy
2025-05-14
ASCGT Meeting Navigates Biotech Downturn After Multi-Year Slump
2025-05-14
EVENT
2025-05-13
ASGCT 28th Annual Meeting 2025
New Orleans, U.S.A.
2025-05-30
ASCO Annual Meeting 2025
Chicago, U.S.A
2025-06-11
ISSCR 2025 Annual Meeting
Hong Kong
2025-06-16
US BIO International Convention
Boston, U.S.A.
Scroll to Top